News

Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms Permira and Nordic Capital. Apparently, the board of directors of the company plan to unanimously...

The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of almost $8 billion in 2025 year-to-date. It has emerged as a biopharma innovation hub...

The head of the Food and Drug Administration office, overseeing vaccines and gene therapy, Vinay Prasad leaves the FDA after taking over his job just three months before. Department of Health and Human Services spokesperson, Andrew Nixon, confirmed his departure...

In a startling figure, multidrug-resistant bacteria kill almost 5 million people every year, with newly resistant germs emerging faster than the scientists can actually develop the treatments. The researchers have now gone on to develop a platform which can go ahead...

In an industry driven by both compliance and consumer confidence, pharmaceutical and nutraceutical brands are increasingly turning toward robust and reusable packaging alternatives. One solution gaining significant traction is the custom medicine tin container—a durable, FDA-compliant packaging form that...

In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted approval by the European Commission. It is well to be noted that Sarclisa has received...

The European Union is going to pay the US a tariff rate of 15% when it comes to pharmaceutical products as part of a new trade deal between the two countries, although there are uncertainties looming on the future...